Medical Developments International Limited · ASX:MVP
Medical Developments International — Non-Deal Roadshow (September 2015)
35 slides from Medical Developments International's roadshow presentation, Sep 9, 2015
Slide 1: Medical Developments International
For personal use only Medical Developments International
Slide 2: Vision
Vision For personal use only Medical Developments International (MDI) is a leading Emergency Medicine Company. Our aim is to: 1. Dominate the analgesic trauma and minor surgical procedures market domestically and internationally. 2. Dominate the Respiratory Medical Devices market domestically and in
Slide 3: Vision
Vision For personal use only MDI is working on and delivering two significant business opportunities. Both opportunities are “company making”. The risk profile of these opportunities is relatively low and well understood. Penthrox: Our regulatory initiatives, if successful, will transform the compan
Slide 4: Two world class opportunities: Penthrox
Two world class opportunities Penthrox For personal use only • Significant competitive advantages to other analgesics. • Fast, safe, rapid on-set, effective, cost-competitive, self administered. • No needles, non-opiate, easy to store & transport. • Building world class regulatory dossier to enable
Slide 5: Two world class opportunities: Respiratory Medical Devices
Two world class opportunities Respiratory Medical Devices For personal use only • Leading patented asthma & COPD medicine delivery devices. • Low resistance, more efficient medicine dosage delivery. • Won international tenders and major contracts in NZ, Canada, Germany & Australia to supply “Space C
Slide 6: MDI Corporate Overview
MDI Corporate Overview For personal use only Three business divisions • Pharmaceutical • Medical devices • Veterinary. We have a widely recognised portfolio of brands such as • Penthrox • Space Chamber • Space Chamber Plus • OXI-Port • OXI-Sok • KAB Absorber • OXI-Life
Slide 7: MDI Corporate Overview
MDI Corporate Overview For personal use only Net Profit Total Earnings Before Net Profit After Tax Sales Interest and Tax After Tax $1.529m 24% 191% 75% up on prior period up on prior period up on prior period Bank Cash Flows From Debt * Operating Activities $2.46m * Net bank debt of nil when combin
Slide 8: MDI Corporate Overview
MDI Corporate Overview For personal use only Results FY15 FY14 Growth $’000 $’000 Sales 11,608 9,365 24% EBITDA 2,509 976 157% EBIT 2,251 776 191% NPAT 1,529 876 75%
Slide 9: MDI Corporate Overview
MDI Corporate Overview For personal use only MDI is recognised as a leader in pain relief, emergency medical devices; oxygen therapies and respiratory products. Our products are the first choice of professionals in the hospital, pre-hospital, first aid environments, universities and veterinary insti
Slide 10: MDI Pharmaceutical: Penthrox
MDI Pharmaceutical For personal use only Penthrox® • Inhalational analgesic • Demonstrated safety and efficacy profile • Only manufacturer in the world • Sold in Australia, N.Z, GCC South America, Eastern Europe & others • Manufactured in GMP compliant plant
Slide 11: Penthrox Clinical application
Penthrox Clinical application For personal use only Painful procedures • Burn injuries Cosmetic Dentistry Surgery • Cutaneous excisions • Breaks, • Liquid nitrogen fractures and Military Consulting removals of skin- dislocations Rooms cancers, warts, etc • Abdomen pain • Invasive • Chest pain Ambula
Slide 12: Penthrox: Benefits to medical professionals
Penthrox Benefits to medical professionals For personal use only Rapid onset of Minimal waiting time before a painful procedure can be performed (3 minutes) and rapid pain relief when a patient is action treated for burns, trauma, etc. Inhaled self- Medical professionals can perform a procedure/atte
Slide 13: Penthrox: Benefits over Nitrous Oxide
Penthrox Benefits over Nitrous Oxide For personal use only Penthrox® does not effect vital signs; no clinical depression of respiration or circulation at low analgesic dosing. Self-administration, easy to use and administer. Compact and can be used in any location or situation. No risk of overdose.
Slide 14: Penthrox: Benefits over Morphine
Penthrox Benefits over Morphine For personal use only The benefits of using Penthrox® over Morphine are the same as detailed for Nitrous. In addition there are a number of specific benefits Penthrox has over Morphine which include: • Penthrox can be used on children, Morphine often cannot. • Penthro
Slide 15: Penthrox Future: CSIRO manufacturing deal
Penthrox Future For personal use only MDI has signed a deal with CSIRO to develop a new manufacturing technique for Penthrox If successful this will provide MDI with: 1. World leading intellectual property 2. Very significant increased production capacity 3. Very significant reduction in cost to man
Slide 16: Penthrox Future: regulatory dossier
Penthrox Future For personal use only Our aim is to create a world class regulatory dossier capable of gaining approval to sell Penthrox anywhere in the world. MDI has spent more than $7 million on developing a regulatory dossier capable of getting Penthrox approved for sale in other countries. Our
Slide 17: Penthrox Future: European market potential
Penthrox Future For personal use only MDI is working on regulatory approvals to expand into new countries in Europe, Central America, Canada, Asia, Africa, Russia, Israel, Saudi Arabia. The following numbers are MDI estimates of the market potential for Penthrox in Europe: AUD million EUROPE Penthro
Slide 18: Penthrox Future
Penthrox Future For personal use only Our plan is to use the Regulatory dossier to improve the positioning and obtain approvals to sell Penthrox around the world. We are developing new Penthrox products which could deliver IP protection. We are developing a new manufacturing methodology to make Pent
Slide 19: MDI Medical Respiratory division
MDI Medical Respiratory division For personal use only Since 1985 Medical Developments International has invested significant R&D resources to improving the delivery of Asthma and COPD medication. In 2011 MDI launched the Space Chamber Plus® and the Compact Space Chamber Plus® in the Australian and
Slide 20: Respiratory division product range
MDI Medical Respiratory division For personal use only MDI offers a range of innovative world leading devices that can be used to help patients manage and take control of their asthma and COPD. • Space Chamber Plus® aerosol spacer • Space Chamber® re-usable • Compact Spacer Chamber Plus® • Breath-Al
Slide 21: MDI Space Chamber Plus
MDI Medical Respiratory division For personal use only MDI Space Chamber Plus ® • Recently approved by the FDA for sale in the USA. • Recently registered by MHRA for full reimbursement. • Won an international tender in New Zealand to supply MDI’s range of asthma products exclusively for three years.
Slide 22: MDI Space Chamber Plus features
MDI Medical Respiratory division For personal use only MDI Space Chamber Plus ® • New patent cross valve technology • Universal end suitable for all Metered Dose Inhalers • Compact design • Provides very low resistance for both inhalation and exhalation • Enables unrestricted and continuous breathin
Slide 23: Space Chamber Plus: world best practice
MDI Medical Respiratory division For personal use only The MDI Space Chamber Plus®is worlds best practice for delivering Asthma medications References 1. Laboratory Usage of respiratory spacers and the delivered Fluticasone (Flixotide) dose of commonly used spacers available in Australia and New Zea
Slide 24: Respiratory division Future: markets
Respiratory division Future For personal use only We now have business and are making sales in: Australia UK Singapore Hong Kong Canada Malaysia Belgium Germany Netherlands Asia Greece Italy Spain USA Denmark New Zealand UAE Austria Switzerland
Slide 25: Respiratory division Future: new products
Respiratory division Future For personal use only MDI is investing heavily in developing new and innovative products • Anti static spacers • Anti static mask – (1st of its kind) • Electronic peak flow • Smart phone asthma & COPD applications
Slide 26: Rescue and resuscitation
MDI Medical Rescue and resuscitation For personal use only Our emergency medical equipment business has grown significantly since FY2011. MDI is the preferred supplier in a number of markets including: Ambulance, Non-emergency transport and Emergency First Aid Various public and private health secto
Slide 27: MDI Medical devices
MDI Medical For personal use only Design, assemble and test a wide range of medical devices ISO 13485 & GMP compliant assembly facilities Over 30 devices in product portfolio Focus on respiratory system and oxygen delivery • Asthma management • Oxygen delivery and equipment • CO2 absorbers • Ventila
Slide 28: MDI Veterinary
MDI Veterinary For personal use only Design, assemble and test a wide range of veterinary devices Focus on anaesthesia and surgical consumables Anaesthesia • Anaesthetic machines (closed circuit system) • Breathing circuits • Vaporisers
Slide 29: MDI Global Strategy
New and revised MDI materials and process Global Strategy (lowest cost producer and For personal use only significant IP)
Slide 30: MDI Global Strategy
New and revised MDI materials and process Global Strategy (lowest cost producer and For personal use only significant IP) Product innovation (worlds best delivery devices and significant IP)
Slide 31: MDI Global Strategy
New and revised MDI materials and process Global Strategy (lowest cost producer and For personal use only significant IP) Product innovation (worlds best delivery devices and significant IP) Regulatory Approval and new markets
Slide 32: MDI Global Strategy
New and revised MDI materials and process Global Strategy (lowest cost producer and For personal use only significant IP) Product innovation (worlds best delivery devices and significant IP) Clinical trials (Commercial clinical studies to support marketing and product development) Regulatory Approva
Slide 33: MDI Global Strategy
New and revised MDI materials and process Global Strategy (lowest cost producer and For personal use only significant IP) New Business Partners Product innovation (worlds best delivery devices and significant IP) Clinical trials (Commercial clinical studies to support marketing and product developme
Slide 34: Contact details
Contact details For personal use only HEAD OFFICE Factory 6 / 56 Smith Road PO Box 21 Springvale, VIC. 3171 Sandown Village, VIC. Australia Tel: +61 3 9547 1888 Fax: +61 3 9547 0262 Web: www.medicaldev.com
Slide 35: Forward looking statements
Forward looking statements For personal use only This document contains certain forward looking statements relating to Medical Development International’s business, which can be identified by the use of forward looking terminology such as “promising”, “plans”, “anticipated”, “will”, “project”, “beli
Medical Developments International — Non-Deal Roadshow (September 2015) on 6ix